Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × relacorilant × Clear all

Phase

Status

Completed 8 Recruiting 3 Active not recruiting 2 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1

Interventions

Cyclophosphamide 387 Carboplatin 337 Gemcitabine 328 pembrolizumab 323 Cisplatin 323 Radiotherapy 295 Paclitaxel 294 Docetaxel 283 Bevacizumab 250 Rituximab 233 Capecitabine 222 Nivolumab 215 Dexamethasone 202 Fluorouracil 188 fludarabine 175 Oxaliplatin 175 Doxorubicin 153 Pemetrexed 148 Irinotecan 148 Leucovorin 142 Etoposide 142 Cytarabine 131 Bortezomib 128 fludarabine phosphate 126 Cetuximab 126 Lenalidomide 123 Erlotinib Hydrochloride 120 Filgrastim 119 Temozolomide 113 Radiosurgery 111

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04329949 2023-11-18

RELIANT

Corcept Therapeutics

Phase 3 Terminated

43 enrolled 17 charts

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡